Janux Therapeutics (JANX) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Janux Therapeutics (JANX) over the last 5 years, with Sep 2025 value amounting to -$0.39.
- Janux Therapeutics' EPS (Weighted Average and Diluted) rose 23.53% to -$0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.67, marking a year-over-year decrease of 43.97%. This contributed to the annual value of -$1.28 for FY2024, which is 3.03% up from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' EPS (Weighted Average and Diluted) is -$0.39, which was up 29.09% from -$0.55 recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' EPS (Weighted Average and Diluted) registered a high of -$0.11 during Q2 2024, and its lowest value of -$0.90 during Q2 2021.
- For the 3-year period, Janux Therapeutics' EPS (Weighted Average and Diluted) averaged around -$0.36, with its median value being -$0.38 (2025).
- Per our database at Business Quant, Janux Therapeutics' EPS (Weighted Average and Diluted) soared by 73.81% in 2024 and then plummeted by 400.00% in 2025.
- Over the past 5 years, Janux Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.29 in 2021, then slumped by 34.48% to -$0.39 in 2022, then spiked by 38.46% to -$0.24 in 2023, then plummeted by 45.83% to -$0.35 in 2024, then rose by 23.53% to -$0.39 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.39 for Q3 2025, versus -$0.55 for Q2 2025 and -$0.38 for Q1 2025.